Počet záznamov: 1
terapia antiretrovírusová vysoko aktívna
SYS d023241 LBL 00000cz--a2200000n--4500 005 20250606214333.9 008 000621|||anznnbabn-----------|-a|a------ 040 $b slo $a DNLM $d BA006 $d BA006 065 $a E02.319.310.075 066 $a 01 $c 03 150 $a terapia antiretrovírusová vysoko aktívna $x AE $x CL $x EC $x ES $x HI $x IS $x MO $x MT $x NU $x PX $x SN $x ST $x TD $x VE $2 slo 450 $w v $a Combination Antiretroviral Therapy $2 eng 450 $w v $a HAART $2 eng 450 $w v $a Highly Active Antiretroviral Therapy $2 eng 450 $w v $a HAART $2 slo 450 $w v $a terapia antiretrovírusová vysoko účinná $2 slo 450 $w v $a terapia antiretrovírusová vysokoúčinná $2 slo 450 $w v $a terapia antiretrovírusová kombinovaná $2 slo 550 $7 sllk_us_auth*d019380 $Y Anti-HIV Agents $w p $a látky proti HIV 550 $7 sllk_us_auth*d000068257 $Y Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination $w b $a kombinácia efavirenz-emtricitabín-tenofovir disoproxil fumarát 665 $a 2001 $2 eng 665 $a Anti-HIV Agents/therapeutic use (1997-2000) $2 eng 665 $a Drug Therapy, Combination (1997-2000) $2 eng 680 9-
$i Drug regimens, for patients with HIV INFECTIONS, that aggressively suppress HIV replication. The regimens usually involve administration of three or more different drugs including a protease inhibitor. $2 eng 680 $a IM when general; NIM when with specific drugs $2 eng 750 -2
$a Antiretroviral Therapy, Highly Active $2 eng 980 $x M
Počet záznamov: 1